Guests ask us some version of the same question every week: does this actually do anything for my lungs? The honest answer takes longer than a sentence, so this entry is the long version. We went back to the studies people usually mean when they say “research shows”, read what each one measured, and wrote down what it found and what it did not.
Two things up front. First, we run a salt room, so we have a stake in the answer; we have tried to report the papers as they read rather than as we would like them to read. Second, nothing here is medical advice. Salt therapy is a comfort practice. If you live with asthma, COPD or chronic sinus problems, your inhalers, your action plan and your doctor come first, and the salt room comes, at most, alongside them.

First, which “salt room” are we talking about?
The word covers two quite different rooms, and the research only really concerns one of them.
- Active halotherapy rooms use a device called a halogenerator, which grinds pharmaceutical-grade sodium chloride into very fine particles and blows them into the room’s air. This is the version used in the controlled trials below.
- Passive salt rooms are rooms decorated with salt: salt brick walls, salt on the floor, salt lamps. They can be lovely places to sit, but without a generator there is very little salt in the air you breathe.
Cleveland Clinic’s article on salt therapy draws the same line, calling the active room the truer form of halotherapy and the passive version more of a meditative space. When you read a claim about salt rooms, it is worth asking which kind of room the claim is about. Our own halotherapy room runs a generator; the décor is there for the mood, not the dose.
Older studies also talk about speleotherapy, which means time spent in real salt mines or caves, often for weeks at a stretch in Central and Eastern Europe. That is a different exposure again, with different air, temperature and duration, and it should not be read as evidence for a 45-minute session in a strip-mall studio.
Asthma: the strongest evidence, and still a small pile
Asthma is where most of the controlled work has been done, and it is the closest thing the field has to a positive signal. It is also small.
The Finnish adult trial (Hedman et al., 2006). Researchers in Lappeenranta took 32 adults with asthma who were already on low to moderate doses of inhaled steroids and who showed bronchial hyperresponsiveness, meaning their airways narrowed easily when challenged. Seventeen were randomised to a real salt chamber and fifteen to a placebo chamber. Sessions lasted 40 minutes, five times a week, for two weeks.
What changed: the airways in the salt group became less reactive. Nine of the patients in the active group (56%) showed at least a one-step improvement in responsiveness, against two (17%) in the placebo group, and six patients in the salt group (38%) stopped being classed as hyperresponsive at all, against none on placebo. What did not change: peak flow and FEV1, the everyday lung function numbers, stayed where they were. The authors’ conclusion was careful: salt chamber treatment reduced airway hyperresponsiveness as an add-on to steroids, and its possible role as a complement to medication “cannot be excluded”. That is a modest, specific finding, not a cure.
The Israeli children’s trial (Bar-Yoseph et al., 2017). A team at Rambam Health Care Campus in Haifa randomised 55 children aged 5 to 13 with mild asthma, none on anti-inflammatory medication, into salt rooms with a halogenerator (29 children) or identical rooms without one (26 children). Fourteen sessions over seven weeks. Neither the families nor the assessors knew which room was which.
The pattern looks a lot like the Finnish one. Airway hyperresponsiveness improved in the treatment group and stayed flat in the control group, and quality-of-life scores improved on most measures. Spirometry did not improve, and neither did exhaled nitric oxide, a marker of airway inflammation. The authors called it a pilot and asked for larger, longer randomised trials.
The Cochrane view. The Cochrane review of speleotherapy for asthma, which pooled the cave and mine studies available at the time, found three trials with 124 children between them, only one of reasonable methodological quality. Two reported a short-term benefit on lung function. The reviewers’ verdict was that the evidence “does not permit a reliable conclusion” either way. That review is old and covers a different exposure, but it is still the closest thing to a formal systematic verdict, and it has not been overturned by a big new trial since.
The newer reviews. A 2021 review in Healthcare went through the halotherapy and asthma literature and found that the included studies leaned positive with no reported adverse events, while also saying, plainly, that evidence-based studies on larger populations are needed. Read together, the asthma story is consistent: a small, measurable effect on how twitchy the airways are, some improvement in how people feel, and no shift in the core lung function numbers that doctors use to judge control.

COPD: interest is high, trials are scarce
COPD is the condition we hear about most from older guests, often because a relative read something online. The research is thinner here than for asthma.
The most useful paper is a 2014 review in the International Journal of COPD by Rashleigh, Smith and Roberts. They searched the major databases and found 151 articles. Exactly one was a randomised controlled trial that met their criteria. To have anything to synthesise, they widened the net to three case-control studies, for 1,041 participants in total, and flagged problems with how patients were randomised and selected. Their conclusion is worth quoting nearly in full: recommendations for including halotherapy as a therapy for COPD “cannot be made at this point”, and high-quality studies are needed.
The best-known small study, from Iasi in Romania (Cernomaz et al., 2007), gave 35 adults with moderate to severe COPD a personal dry salt inhaler for up to 30 minutes a day on top of their usual treatment. Over three months, spirometry did not change in a statistically meaningful way, but the six-minute walk test and a respiratory quality-of-life questionnaire improved. There were no serious adverse events; some people reported a sore throat after more than 15 minutes of continuous exposure, which settled when they paused. The study had no placebo group, and the authors themselves noted that a placebo effect could not be ruled out.
So for COPD the fair summary is: some people report feeling better, the lung-function numbers do not move in the studies we have, and nobody has run the kind of trial that would settle it. If you have COPD and want to try a session, treat it as a comfort experiment and keep every prescribed treatment exactly as it is.
Sinus and allergy complaints: where the marketing outruns the papers
Sinus congestion and allergies are probably the most common reason people book a first session, and they are where the gap between promotion and evidence is widest.
Saline does have a real place in sinus care, but in liquid form: rinses and sprays. Cleveland Clinic’s piece makes this distinction directly. Saline solutions for the nose have evidence behind them; breathing dry salt particles in a room is a different thing that remains unverified. When a studio cites “saline research” to sell a salt room, it is usually borrowing evidence from the rinse bottle.
The American Lung Association’s take is in the same spirit. Its senior scientific advisor, Dr. Norman Edelman, describes the plausible mechanism: fine salt particles land on the airway lining, draw water in, and thin mucus so it is easier to clear. He also points out that these rooms are largely free of allergens, which may be part of why people with allergic airways feel comfortable in them. The same article states there are no evidence-based findings to build guidelines on, and that salt therapy “should definitely be discussed with your doctor”.
What we tell guests with sinus complaints: you may well feel clearer for a while after a session, the way many people feel clearer after a steamy shower or a walk by the sea. That is a real experience. It is not the same as a treatment, and it should not replace whatever your doctor has recommended.

Why the evidence stays thin
People sometimes assume that if salt rooms worked, someone would have proven it by now. A few reasons it is genuinely hard:
- Blinding is difficult. Salt rooms look, smell and taste of salt. The better trials used identical rooms with the generator switched off, which is clever, but most studies did not.
- There is no standard dose. Generators, particle sizes, room volumes and session lengths vary from one studio to the next. Cleveland Clinic calls the industry “the Wild West” for exactly this reason. A trial in one room says little about another.
- Nobody funds big trials. Salt cannot be patented. There is no sponsor with a reason to pay for a several-hundred-patient study.
- The outcomes that move are the soft ones. Quality of life and airway reactivity shift; spirometry mostly does not. Those softer outcomes matter to patients, but they are also the outcomes most open to expectation effects.
None of this means salt rooms do nothing. It means the honest position is “small studies, some encouraging signals, not proven”.
Who should check with a doctor first
Cleveland Clinic notes that some people cough more after a session, and the ALA raises a hygiene point worth asking any studio about: warm rooms can be good places for bacteria to grow if they are not kept clean. And the particles are meant to act on the airway lining, which is the whole idea, so very sensitive airways can react to them. We ask guests to talk to their doctor before booking if they:
- have asthma that is not well controlled, or have had a flare-up recently;
- have COPD, especially if they use oxygen;
- are pregnant;
- have a fever, an active chest infection or a contagious cold;
- have any condition their doctor has told them affects their breathing.
If you have asthma, bring your reliever inhaler into the room with you. That is not a formality.
How to use a session sensibly
If you have read this far and still want to try it, which is a perfectly reasonable choice for many people, here is how we suggest going about it:
- Keep your treatment unchanged. No study above tested salt rooms instead of medication. The Finnish trial tested it on top of inhaled steroids.
- Start short. A first session of 30 to 45 minutes is plenty. Our session information page explains how we pace first visits.
- Notice how you feel, honestly. Some people feel clearer and calmer. Some feel nothing. A few feel a tickle in the throat. All three are normal.
- Ask the studio what it runs. Is there a halogenerator? How often is it serviced, and how is the room cleaned and ventilated? Our FAQ answers those questions for our own room.
- Pair it with the boring habits. Sleep, hydration and good indoor air do more for breathing comfort than any single session. We wrote more about that in Salt Air and Seasonal Breathing Wellness.
The short version
- Asthma: two small randomised trials, one in adults and one in children, found less reactive airways and better quality of life, with no change in standard lung function. Promising, small, unconfirmed.
- COPD: one randomised trial worth the name in a 2014 review, some quality-of-life signals, no basis yet for recommending it as therapy.
- Sinuses and allergies: a plausible mechanism and plenty of happy guests, but the solid saline evidence belongs to rinses and sprays, not to dry salt in the air.
We will keep reading as new trials come out, and update this page when they change the picture.
Sources
- The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics (Hedman et al., Allergy, 2006) pubmed.ncbi.nlm.nih.gov
- Halotherapy as asthma treatment in children: a randomized, controlled, prospective pilot study (Bar-Yoseph et al., Pediatric Pulmonology, 2017) pubmed.ncbi.nlm.nih.gov
- Speleotherapy for asthma — Cochrane Database of Systematic Reviews (Beamon et al.) pubmed.ncbi.nlm.nih.gov
- Speleotherapy (exposure to salt air, usually underground) for asthma — Cochrane plain language summary cochrane.org
- A review of halotherapy for chronic obstructive pulmonary disease (Rashleigh et al., 2014) pmc.ncbi.nlm.nih.gov
- The effect of a dry salt inhaler in adults with COPD (Cernomaz et al., Pneumologia, 2007) pubmed.ncbi.nlm.nih.gov
- Halotherapy: An Ancient Natural Ally in the Management of Asthma, a comprehensive review (Crisan-Dabija et al., Healthcare, 2021) pmc.ncbi.nlm.nih.gov
- Promising or Placebo? Halo Salt Therapy — American Lung Association lung.org
- What Is Salt Therapy? — Cleveland Clinic health.clevelandclinic.org
This entry is for informational purposes only and is not medical advice. Salt therapy is a comfort practice, not a treatment — consult a qualified healthcare professional about your specific situation.